Clinical Trial Update: Pretreatment With Valproate Prior to Immunotherapy Targeting Cluster of Differentiation Antigen 20 in Chronic Lymphocytic Leukemia [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 trial evaluated pretreatment with valproate before CD20-targeted immunotherapy in chronic lymphocytic leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Valproate (valproate)

Snippet

Sponsor: Lund University Hospital | Conditions: Chronic Lymphocytic Leukemia | EARLY_Phase 1 | Status: COMPLETED